iVIGA Tap Factory Supplier
Ove tri zdravstvene tehnologije za otkrivanje toaleta bit će klinički testirane u SAD-u, Izrael i Japan
Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 June. The technology gains life-saving medical insights by analysing human excrement. Kompanija je prijavila seriju od tri patenta koji pokrivaju elemente svog medicinskog senzora za toalet.
Three Toilets Detection Health Technologies
The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, Evropa, Japan i Kina.
A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, OutSense tehnologija može identificirati izvor krvi duž gastrointestinalnog trakta.
A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.
Prema riječima izvršnog direktora OutSensea Yfata Scialoma, who predicts that “sa eksplozijom digitalne medicine, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, upalne bolesti crijeva i infekcije urinarnog trakta.
Its solution consists of a multispectral optical sensor, izvor svjetlosti i autonomni uređaj za ekranizaciju koji uključuje WiFi vezu. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.
OutSense has developed tools to diagnose abnormalities in human excreta. Informacije dobijene iz uzorkovane krvi, u kombinaciji s dodatnom analizom vremena od krvarenja do izlučivanja, daje detalje o patologiji krvarenja. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.
At the beginning of June, OutSense je najavio da će CommuniCare, velika zdravstvena kompanija sa više od 90 healthcare facilities in the US, ove godine će početi sa pilotiranjem svoje tehnologije. Pored ovog pilota, OutSense also plans to conduct clinical trials in Israel and Japan.
Visit More News at Viga.cc News